ROBERT W. PANGIA - Corporate Board Profile

BIOGEN INC.

Filing Date	Source Excerpt
2014-04-30	Robert W. Pangia Age: 62 Director since: 1997 Committee Memberships: Compensation and Management Development (Chair)
2015-04-30	Robert W. Pangia Age: 63 Committee Memberships: Compensation and Management Development (Chair), Finance Mr. Pangia served as a director of the Company from 1997 to 2003 and has served as a director since 2003.
2016-04-15	Mr. Pangia, 64, served as a director of the Company from 1997 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC's merger with Biogen Inc. Mr. Pangia has been the Chief Executive Officer of Ivy Sports Medicine, LLC, a medical device company, since 2011. He has also been a partner in Ivy Capital Partners, LLC, the general partner of Ivy Healthcare Capital, L.P., a private equity fund specializing in healthcare investments, since 2003. From October 2007 to October 2009, he served as the Chief Executive Officer of Highlands Acquisition Corp., a special purpose acquisition company. From 1996 to 2003, Mr. Pangia was self-employed as an investment banker. From 1987 to 1996, he held various senior management positions at PaineWebber, a financial services company, including Executive Vice President and Director of Investment Banking for PaineWebber Incorporated of New York, member of the board of directors of PaineWebber, Inc., Chairman of PaineWebber Properties, Inc., and member of several of PaineWebber's executive and operating committees. Mr. Pangia has significant financial acumen and breadth of expertise within the healthcare industry. Biogen Committee Memberships: Compensation and Management Development (Chair), Finance. 2015 Director Compensation: $460,517.
2017-04-26	Mr. Pangia, 65, served as a director of the Company from 1997 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC's merger with Biogen Inc. Mr. Pangia has significant financial acumen and breadth of expertise within the healthcare industry. Biogen Committee Memberships: Compensation and Management Development (Chair), Finance. 2016 Director Compensation: $479,431.
2018-04-27	Mr. Pangia, 66, served as a director of the Company from 1997 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC’s merger with Biogen, Inc. Mr. Pangia has been a partner in Ivy Capital Partners, LLC, the general partner of Ivy Healthcare Capital, L.P., a private equity fund specializing in healthcare investments, since 2003. From 2011 to 2016 he was also the Chief Executive Officer of Ivy Sports Medicine, LLC, a medical device company. From October 2007 to October 2009, he also served as the Chief Executive Officer of Highlands Acquisition Corp., a special purpose acquisition company. From 1996 to 2003, Mr. Pangia was self-employed as an investment banker. From 1987 to 1996, he held various senior management positions at PaineWebber, a financial services company, including Executive Vice President and Director of Investment Banking for PaineWebber Incorporated of New York, a member of the Board of Directors of PaineWebber, Inc., Chairman of PaineWebber Properties, Inc. and a member of several of PaineWebber’s executive and operating committees. Mr. Pangia has significant financial acumen and breadth of expertise within the healthcare industry. Biogen Committee Memberships: Compensation and Management Development (Chair), Finance. 2017 Director Compensation: $482,761.
2019-04-30	Mr. Pangia served as a director of the Company from 1997 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC’s merger with Biogen, Inc. Mr. Pangia has been a partner in Ivy Capital Partners, LLC, the general partner of Ivy Healthcare Capital, L.P., a private equity fund specializing in healthcare investments, since 2003. From 2011 to 2016 he was also the Chief Executive Officer of Ivy Sports Medicine, LLC, a medical device company.
2020-04-20	Mr. Pangia served as a director of the Company from 1997... Biogen Board Committee: Compensation and Management Development (Chair)... 2019 Director Compensation: Robert W. Pangia total $497,095.